International Patent: BIOMARKERS FOR PATIENT SELECTION FOR TREATMENT WITH A TRANSLATION ELONGATION INHIBITOR

GENEVA, Oct. 1 -- THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE filed a patent application (US2026/018652) for “BIOMARKERS FOR PATIENT SELECTION FOR TREATMENT WITH A TRANSLATION ELONGATION INHIBITOR”. With publication no. WO/2026/193122, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 7/06

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....